E²MAO a randomised study
In France, the National Support Agency for the Performance of Health and Medico-Social Establishments (ANAP [Agence Nationale d’Appui à la Performance]) has estimated the cost of screening and prevention for patients at risk of PUs at €1.15 and €56.59 respectively per patient and per day, and the additional treatment costs depending on the severity of the PUs at
€ 3.90 for category I,
€ 7.89 for category II,
€ 28.80 for category III
€ 52.97 for category IV.
19 The duration of the treatment up to healing depends on many factors and on the severity of the PU.
PU(Pressure Ulcers)
The E²MAO study showed the superiority of APAM over VFM in elderly patients who were severely dependent,unable to care for themselves, bedridden more than 15 hours and up to 24 hours a day and at high risk of PUs,evaluated under conditions of similar daily practices. The risk of onset of PUs was 7.57 times greater in the VFM group than in the APAM group.
€ 3.90 for category I,
€ 7.89 for category II,
€ 28.80 for category III
€ 52.97 for category IV.
19 The duration of the treatment up to healing depends on many factors and on the severity of the PU.
PU(Pressure Ulcers)
The E²MAO study showed the superiority of APAM over VFM in elderly patients who were severely dependent,unable to care for themselves, bedridden more than 15 hours and up to 24 hours a day and at high risk of PUs,evaluated under conditions of similar daily practices. The risk of onset of PUs was 7.57 times greater in the VFM group than in the APAM group.
These results suggest the need to consider at the initial management of this type of patients their capacity to reposition themselves efficiently and/or the availability of personnel who can perform repositioning day and night at a frequency of at least every four hours for a patient on a VFM. In the eventthat these conditions are not fulfilled, APAM has shown that it is an effective alternative in the management of these patients. This study provides descriptive information and evidence for practice,showing that the establishment of studies with robust
methodologies is possible to evaluate this type of medical device.
This research must be continued in order to help the caregivers in the detection,assessment, advocacy and prescription of the right support at the right time for the right patient.
APAM—alternating pressure air mattress; VFM—viscoelastic foam mattress
This research must be continued in order to help the caregivers in the detection,assessment, advocacy and prescription of the right support at the right time for the right patient.
APAM—alternating pressure air mattress; VFM—viscoelastic foam mattress
